CASI Pharmaceuticals, Inc. Stock Agreements
7 Contracts & Agreements
- Common Stock Sales Agreement (the Sales Agreement) by and between CASI Pharmaceuticals, Inc. and H.C. Wainwright & Co., LLC dated October 29, 2021 (Filed With SEC on October 29, 2021)
- Description of Common Stock (Filed With SEC on March 30, 2021)
- Description of Common Stock (Filed With SEC on March 16, 2020)
- Amendment No. 1 to Common Stock Sales Agreement by and between CASI Pharmaceuticals, Inc. and H.C. Wainwright & Co., LLC dated July 19, 2019 (Filed With SEC on July 19, 2019)
- Common Stock Sales Agreement (the Sales Agreement) by and between CASI Pharmaceuticals, Inc. and H.C. Wainwright & Co., LLC dated February 23, 2018 (Filed With SEC on February 23, 2018)
- Form of Stock Purchase Agreement (Filed With SEC on October 19, 2017)
- CERTIFICATE OF DESIGNATIONS OF series A preferred stock Of CASIPHARMACEUTICALS, INC. (Filed With SEC on September 19, 2014)
